GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Clean Energy Fuels Corp. (CLNE) CEO and President Andrew J Littlefair sells 8,000 Shares

December 03, 2010 | About:
insider

insider

56 followers
CEO and President of Clean Energy Fuels Corp. (CLNE) Andrew J Littlefair sells 8,000 shares of CLNE on 12/01/2010 at an average price of $13.51 a share.

Clean Energy Fuels Corp. has a market cap of $844.1 million; its shares were traded at around $13.86 with and P/S ratio of 6.5.

CLNE is in the portfolios of Steven Cohen of SAC Capital Advisors.

This is the annual revenues and earnings per share of CLNE over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of CLNE.


CEO Recent Trades:



  • Sell: CEO and President Andrew J Littlefair sold 8,000 shares of CLNE stock on 11/01/2010 at the average price of 14.54. Andrew J Littlefair owns at least 519,919 shares after this. The price of the stock has decreased by 4.68% since.
  • Sell: CEO and President Andrew J Littlefair sold 8,000 shares of CLNE stock on 10/01/2010 at the average price of 14.24. Andrew J Littlefair owns at least 527,919 shares after this. The price of the stock has decreased by 2.67% since.
  • Sell: CEO and President Andrew J Littlefair sold 8,000 shares of CLNE stock on 09/01/2010 at the average price of 14.79. Andrew J Littlefair owns at least 535,919 shares after this. The price of the stock has decreased by 6.29% since.
  • Sell: CEO and President Andrew J Littlefair sold 8,000 shares of CLNE stock on 08/02/2010 at the average price of 19.06. Andrew J Littlefair owns at least 543,919 shares after this. The price of the stock has decreased by 27.28% since.
  • Sell: President & CEO Andrew J Littlefair sold 8,000 shares of CLNE stock on 07/01/2010 at the average price of 14.96. Andrew J Littlefair owns at least 551,919 shares after this. The price of the stock has decreased by 7.35% since.



This is the insider trade history vs. stock price of CLNE. For the complete insider trading history of CLNE, click here.




Directors and Officers Recent Trades:



  • Sell: President, CECC Bradley N Miller sold 378,400 shares of CLNE stock on 11/18/2010 at the average price of 14.03. Bradley N Miller owns at least 2,345,008 shares after this. The price of the stock has decreased by 1.21% since.
  • Sell: President, CECC Bradley N Miller sold 21,600 shares of CLNE stock on 11/16/2010 at the average price of 14.26. Bradley N Miller owns at least 2,723,408 shares after this. The price of the stock has decreased by 2.81% since.
  • Sell: President, CECC Bradley N Miller sold 100,000 shares of CLNE stock on 11/15/2010 at the average price of 14.3. Bradley N Miller owns at least 2,745,008 shares after this. The price of the stock has decreased by 3.08% since.
  • Sell: Director Warren I Mitchell sold 2,000 shares of CLNE stock on 11/01/2010 at the average price of 14.54. Warren I Mitchell owns at least 50,100 shares after this. The price of the stock has decreased by 4.68% since.
  • Sell: SVP, Strategic Development Barclay Corbus sold 5,000 shares of CLNE stock on 10/15/2010 at the average price of 14.61. Barclay Corbus owns at least 7,500 shares after this. The price of the stock has decreased by 5.13% since.


  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.2/5 (5 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK